Objective
Severe malaria is a major cause of preventable morbidity and mortality in endemic regions. 76% of all malaria deaths occur in children <5 years in SSA. While severe malaria constitutes a medical emergency, about one third of children diagnosed with severe malaria suffer from another life-threatening infection, most commonly systemic bacterial infections. Diagnostic differentiation is often not possible in resource limited settings. Ideally, empiric treatment for both aetiologies is warranted. However, often enough either antimalarial or antibiotic therapy is administered, putting the patient at an increased risk of death. Additionally, artemisinin partial resistant Plasmodium isolates constitute an increasing therapeutic challenge for currently recommended artesunate monotherapy. Finally, a high proportion of bacterial isolates with resistance against commonly used antibiotics poses a similar therapeutic challenge.
To overcome the 1) lack of adequate initial coverage of antimalarial and antibacterial pathogens, 2) increase of artemisinin partial resistant Plasmodium, and 3)high incidence of antimicrobial drug-resistant bacterial pathogens, we develop an antibiotic-based combination therapy with fosmidomycin-artesunate-clindamycin (FACT) for the simultaneous treatment of severe malaria and bacterial bloodstream infections. FACT includes parenteral artesunate, the currently recommended treatment of severe malaria, coverage of gram-positive and anaerobic bacteria by clindamycin and gram-negative bacteria by fosmidomycin. Clindamycin and fosmidomycin also exert proven synergistic antimalarial activity even in artemisinin resistant isolates. Matching pharmacokinetic parameters and independent modes of action provide further protection against selection for antimalarial drug resistance.
Based on previous clinical trials, this project targets the late clinical development of FACT in a Phase II and Phase III clinical trial for subsequent implementation in health services.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.2.1 - Health
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-JU-RIA - HORIZON JU Research and Innovation Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-JU-GH-EDCTP3-2025-01-two-stage
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
20359 Hamburg
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.